Contrast media or contrast agent is used in medical imaging to enhance the image of body parts generated through X-rays

SEATTLE, WASHINGTON, UNITED STATES, January 4, 2022 /EINPresswire.com/ -- Contrast Media have different properties that make them suitable for use in the radiology setting. They usually have increased viscosity and osmolality. Their properties also play a role in the contrast reactions. Ionic agents are those that have more molecules per kilogram of water. However, gadolinium-based contrasts have varying radiodensity and may be more appropriate in certain circumstances. The patient is generally not at risk for a reaction to these compounds, but they should be monitored carefully for any serious side effects.

The use of contrast media has increased dramatically over the years. They are often used in special procedures. While the difference in tissue density is not large enough to allow for adequate contrast, they do give a better picture of the body. Intravascular contrast agents are the most common and widely used in CT and MRI scans. As a result, a high-density image is more readily available. This is important to ensure that the patient is safe during the procedure.

𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗣𝗗𝗙 𝗕𝗿𝗼𝗰𝗵𝘂𝗿𝗲 𝘄𝗶𝘁𝗵 𝗟𝗮𝘁𝗲𝘀𝘁 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 @ https://www.coherentmarketinsights.com/insight/request-pdf/1210

𝗥𝗲𝗰𝗲𝗻𝘁 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁𝘀

Major players operating in the global contrast media/contrast agent market are focused on approval and launch of new products to expand their product portfolio. For instance, in July 2019, Bracco Diagnostics Inc., a subsidiary of Bracco Imaging S.p.A., launched an interactive and customizable media kit for enhancing the user experience and increasing physician referrals.

𝗚𝗹𝗼𝗯𝗮𝗹 𝗖𝗼𝗻𝘁𝗿𝗮𝘀𝘁 𝗠𝗲𝗱𝗶𝗮/𝗖𝗼𝗻𝘁𝗿𝗮𝘀𝘁 𝗔𝗴𝗲𝗻𝘁 𝗠𝗮𝗿𝗸𝗲𝘁: 𝗗𝗿𝗶𝘃𝗲𝗿𝘀

High prevalence of cancer is expected to propel growth of the global contrast media/contrast agent market over the forecast period. For instance, according to the study, ‘Cancer statistics for adults aged 85 years and older, 2019’, published in ACS CA: A Cancer Journal for Clinicians, in August 2019, in 2019, the projected number of cancer cases and deaths was 140,690 and 103,250 respectively, among adults aged 85 years and older in the U.S.

Moreover, approval and launch of new products is also expected to propel growth of the global contrast media/contrast agent market over the forecast period. For instance, in March, 2017, GE Healthcare launched Clariscan, a gadolinium-based contrast agent designed to support effective visualization of abnormalities in the spine, brain and associated tissues.

𝗚𝗹𝗼𝗯𝗮𝗹 𝗖𝗼𝗻𝘁𝗿𝗮𝘀𝘁 𝗠𝗲𝗱𝗶𝗮/𝗖𝗼𝗻𝘁𝗿𝗮𝘀𝘁 𝗔𝗴𝗲𝗻𝘁 𝗠𝗮𝗿𝗸𝗲𝘁: 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀

Expansion of indication is expected to offer lucrative growth opportunities for players in the global contrast media/contrast agent market. For instance, in May 2017, the Food and Drug Administration expanded indication for GE Healthcare’s Visipaque (iodixanol) for use in coronary computed tomography angiography (CCTA) for diagnostic evaluation of adult and pediatric patients 12 years of age or older with suspected coronary artery disease.

𝗠𝗮𝗿𝗸𝗲𝘁 𝗧𝗿𝗲𝗻𝗱𝘀

Major players operating in the global contrast media/contrast agent market are focused on approval and launch of new products to expand their product portfolio. For instance, in July 2019, the U.S. Food and Drug Administration approved Bayer HealthCare’s Gadavist (gadobutrol) injection to be used as the first contrast agent for cardiac MRI in the patients suspected to suffer from the coronary artery disease.

𝗟𝗶𝗺𝗶𝘁𝗲𝗱 𝗧𝗶𝗺𝗲 𝗢𝗳𝗳𝗲𝗿!

𝗚𝗲𝘁 𝗙𝗹𝗮𝘁 𝟯𝟬% 𝗢𝗳𝗳

𝗣𝘂𝗿𝗰𝗵𝗮𝘀𝗲 𝗧𝗵𝗶𝘀 𝗣𝗿𝗲𝗺𝗶𝘂𝗺 𝗥𝗲𝗽𝗼𝗿𝘁 𝗧𝗼 𝗔𝗰𝗰𝗲𝘀𝘀 𝗙𝘂𝗹𝗹 𝗜𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 @ https://www.coherentmarketinsights.com/insight/buy-now/1210

𝗚𝗹𝗼𝗯𝗮𝗹 𝗖𝗼𝗻𝘁𝗿𝗮𝘀𝘁 𝗠𝗲𝗱𝗶𝗮/𝗖𝗼𝗻𝘁𝗿𝗮𝘀𝘁 𝗔𝗴𝗲𝗻𝘁 𝗠𝗮𝗿𝗸𝗲𝘁: 𝗥𝗲𝘀𝘁𝗿𝗮𝗶𝗻𝘁𝘀

Side effects of contrast agents such as kidney diseases and high cost associated with the contrast media injectors are some of the factors hindering growth of the global contrast media/ contrast agent market.

𝗚𝗹𝗼𝗯𝗮𝗹 𝗖𝗼𝗻𝘁𝗿𝗮𝘀𝘁 𝗠𝗲𝗱𝗶𝗮/𝗖𝗼𝗻𝘁𝗿𝗮𝘀𝘁 𝗔𝗴𝗲𝗻𝘁 𝗠𝗮𝗿𝗸𝗲𝘁: 𝗞𝗲𝘆 𝗧𝗮𝗸𝗲𝗮𝘄𝗮𝘆𝘀

Major players operating in the global contrast media/contrast agent market are focused on adopting partnership strategies to enhance their market share. For instance, in December 2014, nanoPET Pharma GmbH partnered with Boehringer Ingelheim Corporation under which nanoPET led the development of contrast agents for studies in both basic and pre-clinical research.

Major players operating in the global contrast media/contrast agent market are also focused on approval and launch of new products to expand their product portfolio. For instance, in September 2019, Bayer HealthCare launched Medrad Stellant Flex CT injection system in order to offer user-driven system, individualized patient protocols and personalized imaging. Similarly, in 2016, Bayer AG received the U.S Food and Drug Administration’s approval for Gadavist (gadobutrol) injection for use with magnetic resonance angiography (MRA) to evaluate renal artery disease use in adult and pediatric patients.

𝗚𝗹𝗼𝗯𝗮𝗹 𝗖𝗼𝗻𝘁𝗿𝗮𝘀𝘁 𝗠𝗲𝗱𝗶𝗮/𝗖𝗼𝗻𝘁𝗿𝗮𝘀𝘁 𝗔𝗴𝗲𝗻𝘁 𝗠𝗮𝗿𝗸𝗲𝘁: 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻

𝐎𝐧 𝐭𝐡𝐞 𝐛𝐚𝐬𝐢𝐬 𝐨𝐟 𝐦𝐞𝐝𝐢𝐚 𝐭𝐲𝐩𝐞, 𝐜𝐨𝐧𝐭𝐫𝐚𝐬𝐭 𝐦𝐞𝐝𝐢𝐚/𝐜𝐨𝐧𝐭𝐫𝐚𝐬𝐭 𝐚𝐠𝐞𝐧𝐭 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐞𝐝 𝐢𝐧𝐭𝐨:

Microbubble Contrast Media

Iodinated Contrast Media

Barium-Based Contrast Media

Gadolinium-Based Contrast Media

𝐎𝐧 𝐭𝐡𝐞 𝐛𝐚𝐬𝐢𝐬 𝐨𝐟 𝐫𝐨𝐮𝐭𝐞 𝐨𝐟 𝐚𝐝𝐦𝐢𝐧𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧, 𝐜𝐨𝐧𝐭𝐫𝐚𝐬𝐭 𝐦𝐞𝐝𝐢𝐚/𝐜𝐨𝐧𝐭𝐫𝐚𝐬𝐭 𝐚𝐠𝐞𝐧𝐭 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐞𝐝 𝐢𝐧𝐭𝐨:

Oral

Rectal

Intravenous

Urethral

𝐎𝐧 𝐭𝐡𝐞 𝐛𝐚𝐬𝐢𝐬 𝐨𝐟 𝐢𝐧𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧, 𝐜𝐨𝐧𝐭𝐫𝐚𝐬𝐭 𝐦𝐞𝐝𝐢𝐚/𝐜𝐨𝐧𝐭𝐫𝐚𝐬𝐭 𝐚𝐠𝐞𝐧𝐭 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐞𝐝 𝐢𝐧𝐭𝐨:

Neurological Disorders

Nephrological Disorders

Cardiovascular Disorders

Gastrointestinal Disorders

Oncology

Musculoskeletal Disorders

𝐎𝐧 𝐭𝐡𝐞 𝐛𝐚𝐬𝐢𝐬 𝐨𝐟 𝐞𝐧𝐝 𝐮𝐬𝐞𝐫, 𝐜𝐨𝐧𝐭𝐫𝐚𝐬𝐭 𝐦𝐞𝐝𝐢𝐚/𝐜𝐨𝐧𝐭𝐫𝐚𝐬𝐭 𝐚𝐠𝐞𝐧𝐭 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐞𝐝 𝐢𝐧𝐭𝐨:

Hospitals

Ambulatory Surgical Centers

Diagnostic Clinics

𝐎𝐧 𝐭𝐡𝐞 𝐛𝐚𝐬𝐢𝐬 𝐨𝐟 𝐠𝐞𝐨𝐠𝐫𝐚𝐩𝐡𝐲/𝐫𝐞𝐠𝐢𝐨𝐧, 𝐜𝐨𝐧𝐭𝐫𝐚𝐬𝐭 𝐦𝐞𝐝𝐢𝐚/𝐜𝐨𝐧𝐭𝐫𝐚𝐬𝐭 𝐚𝐠𝐞𝐧𝐭 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐞𝐝 𝐢𝐧𝐭𝐨:

North America

Latin America

Europe

Asia Pacific

Middle East

Africa

𝗚𝗲𝘁 𝗦𝗮𝗺𝗽𝗹𝗲 𝗥𝗲𝗽𝗼𝗿𝘁 𝘄𝗶𝘁𝗵 𝗟𝗮𝘁𝗲𝘀𝘁 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 @ https://www.coherentmarketinsights.com/insight/request-sample/1210

𝗠𝗮𝗷𝗼𝗿 𝗣𝗹𝗮𝘆𝗲𝗿𝘀 𝗔𝗿𝗲: Lantheus Medical Imaging, GE Healthcare, Bayer HealthCare, Bracco Imaging S.p.A, NanoPET Pharma GmbH, Guerbet Group, CMC Contrast AB, Daiichi Sankyo, and Subhra Pharma Private Limited

𝐀𝐛𝐨𝐮𝐭 𝐂𝐨𝐡𝐞𝐫𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Mr. Shah
Coherent Market Insights Pvt. Ltd.
+1 206-701-6702
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.